bevacizumab,olaparib
Roche,Merck,Astrazeneca
['ovarian', 'olaparib', 'bevacizumab', 'gyn']
maintenance therapy with olaparib plus bevacizumab extends survival for women with newly diagnosed advanced ovarian cancer and hrd #esmo22 #gyncsm 
#ovca survivor; research advocate; author; co-moderator #gyncsm chat;  #ASCO22 Feature Voice  COI: https://t.co/AUF1EprNVt Opinions are my own.